In silico design of miniprotein to inhibit SARS-CoV-2 variant Omicron spike protein
Omicron is a novel variant of SARS-CoV-2 that is currently spreading globally as the dominant strain. The virus first enters the host cell through the receptor binding domain (RBD) of the spike protein by interacting with the angiotensin-converting enzyme 2 (ACE2). Thus, the RBD protein is an ideal...
Saved in:
Published in | Physical chemistry chemical physics : PCCP Vol. 25; no. 21; pp. 14711 - 14725 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Royal Society of Chemistry
31.05.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 1463-9076 1463-9084 1463-9084 |
DOI | 10.1039/D3CP01167D |
Cover
Loading…